astrazeneca to buy alexion pharmaceuticals in $39 billion deal
Published 3 years ago • 6.8K plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
0:27
astrazeneca buying drug developer alexion for $39 billion
-
1:07:16
astrazeneca's business strategy | earnings call webinar
-
1:14
astrazeneca shares dip after $39 bln alexion deal
-
2:48
astrazeneca acquires alexion for $39 billion - gabelli funds analyst jing he (12.14.2020)
-
1:32
life at alexion: being part of astrazeneca
-
1:55
world’s top 10 pharma companies by 2023 revenue
-
2:06
alexion, astrazeneca rare disease: who we are
-
24:07
bloomberg turnaround: astrazeneca
-
45:19
scientist stories: mia huang, decoding glycans to create new diagnostics and therapeutics
-
33:49
webinar: arovella licenses novel car-inkt cell armouring technology
-
0:35
working at alexion
-
16:33
what's new in mg research: expand study by alexion
-
1:56
alexion | identity diagnosis
-
1:24
advancing diagnostics to improve outcomes in rare disease
-
4:38
how ceo created first authorized antibody treatment for covid-19 -- and became overnight billionaire
-
1:03
delivering hope via transformational research
-
1:36
are novel therapeutics replacing asct?
-
1:51
how pharmacists can improve adherence to novel oral anticoagulants
-
0:42
cultivating a scientific ecosystem
-
27:14
a novel platform for manipulating genes in health and diseases
-
1:07:40
healing signals: delivery of electric currents for therapeutics